These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31987961)

  • 21. Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy.
    Geinitz H; Riegel MG; Thamm R; Astner ST; Lewerenz C; Zimmermann F; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1930-7. PubMed ID: 21514736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining prostate-specific antigen nadir and time to nadir allows for early identification of patients at highest risk for development of metastasis and death following salvage radiation therapy.
    Jackson WC; Johnson SB; Foster B; Foster C; Li D; Song Y; Vainshtein J; Zhou J; Hamstra DA; Feng FY
    Pract Radiat Oncol; 2014; 4(2):99-107. PubMed ID: 24890350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term Outcome of Prostate Cancer Patients Who Exhibit Biochemical Failure Despite Salvage Radiation Therapy After Radical Prostatectomy.
    Ying J; Wang CJ; Yan J; Liauw SL; Straka C; Pistenmaa D; Xie XJ; Lotan Y; Roehrborn C; Kim DN
    Am J Clin Oncol; 2017 Dec; 40(6):612-620. PubMed ID: 26165416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database.
    Moreira DM; Jayachandran J; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Stephenson AJ; Freedland SJ
    BJU Int; 2009 Nov; 104(10):1452-6. PubMed ID: 19466946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early salvage radiation therapy combined with short-term hormonal therapy in recurrent prostate cancer after radical prostatectomy: single-institution 4-year data on outcome, toxicity, health-related quality of life and co-morbidities from 184 consecutive patients treated with 70 Gy.
    Cortés-González JR; Castellanos E; Sandberg K; Eriksson MH; Wiklund P; Carlsson S; Cohn-Cedermark G; Harmenberg U; Gustafsson O; Levitt SH; Lennernäs B; Brandberg Y; Márquez M; Kälkner KM; Nilsson S
    Int J Oncol; 2013 Jan; 42(1):109-17. PubMed ID: 23151842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The PSA-response to salvage radiotherapy after radical prostatectomy correlates with freedom from progression and overall survival.
    Bartkowiak D; Bottke D; Thamm R; Siegmann A; Hinkelbein W; Wiegel T
    Radiother Oncol; 2016 Jan; 118(1):131-5. PubMed ID: 26653358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study.
    Fossati N; Robesti D; Karnes RJ; Soligo M; Boorjian SA; Bossi A; Coraggio G; Di Muzio N; Cozzarini C; Noris Chiorda B; Gandaglia G; Scarcella S; Bartkowiak D; Böhmer D; Shariat S; Goldner G; Battaglia A; Joniau S; Haustermans K; De Meerleer G; Fonteyne V; Ost P; Van Poppel H; Montorsi F; Wiegel T; Briganti A
    Eur Urol; 2019 Oct; 76(4):443-449. PubMed ID: 30799187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved Metastasis-Free and Survival Outcomes With Early Salvage Radiotherapy in Men With Detectable Prostate-Specific Antigen After Prostatectomy for Prostate Cancer.
    Stish BJ; Pisansky TM; Harmsen WS; Davis BJ; Tzou KS; Choo R; Buskirk SJ
    J Clin Oncol; 2016 Nov; 34(32):3864-3871. PubMed ID: 27480153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: comparative analysis of long-term outcomes.
    Mishra MV; Scher ED; Andrel J; Margules AC; Hegarty SE; Trabulsi EJ; Hyslop T; Den RB; Lallas CD; Gomella LG; Dicker AP; Showalter TN
    Am J Clin Oncol; 2015 Feb; 38(1):55-60. PubMed ID: 24051934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: The NRG-GU003 Phase 3 Randomized Clinical Trial.
    Buyyounouski MK; Pugh SL; Chen RC; Mann MJ; Kudchadker RJ; Konski AA; Mian OY; Michalski JM; Vigneault E; Valicenti RK; Barkati M; Lawton CAF; Potters L; Monitto DC; Kittel JA; Schroeder TM; Hannan R; Duncan CE; Rodgers JP; Feng F; Sandler HM
    JAMA Oncol; 2024 May; 10(5):584-591. PubMed ID: 38483412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer-specific Mortality: Competition Between Age and Time to Biochemical Failure.
    Jackson WC; Suresh K; Tumati V; Dess RT; Soni PD; Zhao SG; Zumsteg ZS; Hannan R; Hollenbeck BK; George A; Kaffenberger SD; Salami SS; Hearn JWD; Morgan TM; Mehra R; Schipper M; Feng FY; Desai NB; Spratt DE
    Eur Urol Oncol; 2018 Sep; 1(4):276-282. PubMed ID: 31100248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salvage radiation therapy for prostate cancer patients after prostatectomy.
    Mima T; Ohori M; Hirasawa Y; Mikami R; Arai A; Hashimoto T; Satake N; Gondo T; Nakagami Y; Namiki K; Tokuuye K; Ohno Y
    Jpn J Clin Oncol; 2019 Mar; 49(3):281-286. PubMed ID: 30608594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics?
    Viani GA; Hamamura AC; Correa AC; de Arruda FT
    Int Braz J Urol; 2019; 45(2):237-245. PubMed ID: 30676298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant hormone therapy before salvage radiotherapy for an increasing post-radical prostatectomy serum prostate specific antigen level.
    Tiguert R; Rigaud J; Lacombe L; Laverdière J; Fradet Y
    J Urol; 2003 Aug; 170(2 Pt 1):447-50. PubMed ID: 12853796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes of salvage radiotherapy for PSA-recurrent prostate cancer: validation of the Stephenson nomogram.
    Hugen CM; Polcari AJ; Quek ML; Garza RP; Fitzgerald MP; Flanigan RC
    World J Urol; 2010 Dec; 28(6):741-4. PubMed ID: 20449749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series.
    Gandaglia G; Fossati N; Karnes RJ; Boorjian SA; Colicchia M; Bossi A; Seisen T; Cozzarini C; Di Muzio N; Noris Chiorda B; Zaffuto E; Wiegel T; Shariat SF; Goldner G; Joniau S; Battaglia A; Haustermans K; De Meerleer G; Fonteyne V; Ost P; Van Poppel H; Montorsi F; Briganti A
    Eur Urol; 2018 Apr; 73(4):512-518. PubMed ID: 29229176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study.
    Pisansky TM; Agrawal S; Hamstra DA; Koontz BF; Liauw SL; Efstathiou JA; Michalski JM; Feng FY; Abramowitz MC; Pollack A; Anscher MS; Moghanaki D; Den RB; Stephans KL; Zietman AL; Lee WR; Kattan MW; Stephenson AJ; Tendulkar RD
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1046-1053. PubMed ID: 27745980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer.
    Katz MS; Zelefsky MJ; Venkatraman ES; Fuks Z; Hummer A; Leibel SA
    J Clin Oncol; 2003 Feb; 21(3):483-9. PubMed ID: 12560439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salvage Radiotherapy for Recurrent Prostate Cancer: Can the Prognostic Grade Group System Inform Treatment Timing?
    Tay KJ; Polascik TJ; Howard LE; Salama JK; Schulman AA; Chen Z; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ
    Clin Genitourin Cancer; 2019 Oct; 17(5):e930-e938. PubMed ID: 31257075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer.
    Taylor N; Kelly JF; Kuban DA; Babaian RJ; Pisters LL; Pollack A
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):755-63. PubMed ID: 12788182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.